Drug recall D-1095-2023
Product
Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01
Reason for recall
Subpotent: Out of Specification for Assay Test at the 3-month time point.
Lots and codes
Batch # 19224744
Recall details
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Quantity
- 1,200 bottles
- Distribution
- nationwide in the U.S.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 14, 2023
Related products
- Trandolapril and Verapamil Hydrochloride – drug information
- NDC 68462-295 Trandolapril and Verapamil Hydrochloride · Trandolapril 2 mg/1; Verapamil Hydrochloride 180 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-294 Trandolapril and Verapamil Hydrochloride · Trandolapril 1 mg/1; Verapamil Hydrochloride 240 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-296 Trandolapril and Verapamil Hydrochloride · Trandolapril 2 mg/1; Verapamil Hydrochloride 240 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-329 Trandolapril and Verapamil Hydrochloride · Trandolapril 4 mg/1; Verapamil Hydrochloride 240 mg/1 · Glenmark Pharmaceuticals Inc., USA